)
)
)
Therorna Inc.
Therorna is a clinical-stage biotechnology company. Founded by a team of renowned scientists and experienced returnees in April 2021, Therorna focuses on the research and application of circular RNA technology to innovative medicines and therapies. The company dedicates to addressing unmet medical needs for patients by establishing a rich pipeline for some of the most challenging diseases—such as oncology and autoimmune disorders.
Therorna's three core platforms:
- CircVac - Circular RNA Vaccine Platform: Focusing on oncology
- CircCAR - in vivo CAR-T Platform: Targeting oncology and autoimmune diseases
- CircMab Platform - Using circRNA to encode multi-specific antibodies: Focusing oncology and autoimmune diseases.
Therorna looks forward to building partnerships that will bring these transformative medicines to patients around the world.
)
){kind=logo}
)
){kind=logo}
){kind=logo}
)
)
)
)